These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6223692

  • 1. Effect of dichloromethylene diphosphonate (Cl2MDP) on immune function in breast cancer patients with bone metastases.
    Markkula R, Repo H, Leirisalo M, Blomqvist C, Elomaa I.
    Cancer Immunol Immunother; 1983; 15(2):159-61. PubMed ID: 6223692
    [Abstract] [Full Text] [Related]

  • 2. Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
    Siris ES, Hyman GA, Canfield RE.
    Am J Med; 1983 Mar; 74(3):401-6. PubMed ID: 6219577
    [Abstract] [Full Text] [Related]

  • 3. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC, Meunier PJ, Alexandre CM, Vignon EP.
    J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
    [Abstract] [Full Text] [Related]

  • 4. Controlled clinical study on the use of dichloromethylene diphosphonate in patients with breast carcinoma metastasizing to the skeleton.
    Martoni A, Guaraldi M, Camera P, Biagi R, Marri S, Beghé F, Pannuti F.
    Oncology; 1991 May; 48(2):97-101. PubMed ID: 1825515
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism.
    Elomaa I, Blomqvist C, Porkka L, Holmström T, Laine H.
    Cancer Treat Rep; 1984 Apr; 68(4):655-7. PubMed ID: 6231989
    [Abstract] [Full Text] [Related]

  • 6. [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
    Delmas P, Chapuy MC, Vignon E, Briançon D, Charhon S, Meunier PJ.
    Nouv Presse Med; 1982 Apr 24; 11(19):1471-4. PubMed ID: 6210878
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of two parenteral diphosphonates in hypercalcemia of malignancy.
    Jung A.
    Am J Med; 1982 Feb 24; 72(2):221-6. PubMed ID: 6460442
    [Abstract] [Full Text] [Related]

  • 10. Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.
    Elomaa I, Blomqvist C, Gröhn P, Porkka L, Kairento AL, Selander K, Lamberg-Allardt C, Holmström T.
    Lancet; 1983 Jan 22; 1(8317):146-9. PubMed ID: 6130197
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE, Siris ES, Jacobs TP.
    Bone; 1987 Jan 22; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [Abstract] [Full Text] [Related]

  • 13. Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.
    Attardo-Parrinello G, Merlini G, Pavesi F, Crema F, Fiorentini ML, Ascari E.
    Arch Intern Med; 1987 Sep 22; 147(9):1629-33. PubMed ID: 2957971
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
    Douglas DL, Duckworth T, Kanis JA, Preston C, Beard DJ, Smith TW, Underwood I, Woodhead JS, Russell RG.
    Arthritis Rheum; 1980 Oct 22; 23(10):1185-92. PubMed ID: 6448604
    [Abstract] [Full Text] [Related]

  • 17. [Dichloromethylene diphosphonate in the treatment of lytic bone metastases].
    Chantraine A, Jung A, van Ouwenaller C, Donath A.
    Presse Med; 1984 Feb 25; 13(8):479-82. PubMed ID: 6230629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of bone metastases with dichloromethylene bisphosphonate.
    Francini G, Gonnelli S, Petrioli R, Conti F, Paffetti P, Gennari C.
    J Clin Oncol; 1992 Apr 25; 10(4):591-8. PubMed ID: 1532198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.